Literature DB >> 30034934

Pregnancy-associated plasma protein a in cancer: expression, oncogenic functions and regulation.

Yongchen Guo1, Yonghua Bao1, Dongli Guo2, Wancai Yang1,3.   

Abstract

Pregnancy-associated plasma protein A (PAPPA) is a protease that plays important roles in pregnancy, but interestingly acts as an oncogene outside of pregnancy. This review summarizes the oncogenic roles of PAPPA, including its expression levels in multiple malignancies, regulatory and signaling interactions, and pro-tumor functions, which include promoting tumor cell proliferation, invasion, migration and metastasis. These PAPPA activities are linked to IGFBP-4 proteolysis, increased IFG bioavailability, and activation of the NF-κB, PI3K/AKT and ERK signaling pathways. Therefore, PAPPA could be used as a biomarker for monitoring cancer development and progression as well as a potential therapeutic target.

Entities:  

Keywords:  PAPPA; cancer; prognosis; proliferation; regulation

Year:  2018        PMID: 30034934      PMCID: PMC6048405     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  48 in total

1.  Insulin-like growth factor, insulin-like growth factor-binding protein-4, and pregnancy-associated plasma protein-A gene expression in human granulosa cell tumors.

Authors:  M Alexiadis; P Mamers; S Chu; P J Fuller
Journal:  Int J Gynecol Cancer       Date:  2006 Nov-Dec       Impact factor: 3.437

2.  The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

Authors:  Adam I Riker; Steven A Enkemann; Oystein Fodstad; Suhu Liu; Suping Ren; Christopher Morris; Yaguang Xi; Paul Howell; Brandon Metge; Rajeev S Samant; Lalita A Shevde; Wenbin Li; Steven Eschrich; Adil Daud; Jingfang Ju; Jaime Matta
Journal:  BMC Med Genomics       Date:  2008-04-28       Impact factor: 3.063

Review 3.  The IGF-p53 connection in cancer.

Authors:  Cheryl A Conover
Journal:  Growth Horm IGF Res       Date:  2017-12-02       Impact factor: 2.372

4.  Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells.

Authors:  Madoka Ishikawa; Koji Yoshida; Yoshihiro Yamashita; Jun Ota; Shuji Takada; Hiroyuki Kisanuki; Koji Koinuma; Young Lim Choi; Ruri Kaneda; Toshiyasu Iwao; Kiichi Tamada; Kentaro Sugano; Hiroyuki Mano
Journal:  Cancer Sci       Date:  2005-07       Impact factor: 6.716

Review 5.  The insulin and insulin-like growth factor receptor family in neoplasia: an update.

Authors:  Michael Pollak
Journal:  Nat Rev Cancer       Date:  2012-02-16       Impact factor: 60.716

6.  Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development.

Authors:  Cheryl A Conover; Laurie K Bale; Michael T Overgaard; Edward W Johnstone; Ulla H Laursen; Ernst-Martin Füchtbauer; Claus Oxvig; Jan van Deursen
Journal:  Development       Date:  2004-03       Impact factor: 6.868

7.  Genetic downregulation of pregnancy-associated plasma protein-A (PAPP-A) by bikunin reduces IGF-I-dependent Akt and ERK1/2 activation and subsequently reduces ovarian cancer cell growth, invasion and metastasis.

Authors:  Yoshiko Tanaka; Hiroshi Kobayashi; Mika Suzuki; Yasuyuki Hirashima; Naohiro Kanayama; Toshihiko Terao
Journal:  Int J Cancer       Date:  2004-04-10       Impact factor: 7.396

8.  MicroRNA-141 inhibits vascular smooth muscle cell proliferation through targeting PAPP-A.

Authors:  Yudong Zhang; Bainan Chen; Liu Ming; Hongsong Qin; Liu Zheng; Zhang Yue; Zhixin Cheng; Yannan Wang; Dawei Zhang; Chunmei Liu; Wang Bin; Qingzhi Hao; Fuchen Song; Bo Ji
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  Skp2B overexpression alters a prohibitin-p53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4.

Authors:  Harish Chander; Max Halpern; Lois Resnick-Silverman; James J Manfredi; Doris Germain
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

10.  Protein secretion is required for pregnancy-associated plasma protein-A to promote lung cancer growth in vivo.

Authors:  Hong Pan; Sayaka Hanada; Jun Zhao; Li Mao; Mark Zhi-Qing Ma
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

View more
  10 in total

1.  m6A mRNA methylation regulates the ERK/NF-κB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer.

Authors:  Peng Ruan; Shujun Wang; Chaoyi Yang; Xiaohui Huang; Pengxing Sun; Aili Tan
Journal:  Cell Biol Toxicol       Date:  2022-08-15       Impact factor: 6.819

2.  PAPPA Expression in Indeterminate Thyroid Nodules as Screening Test to Select Patients for Molecular Testing.

Authors:  Carlotta Marzocchi; Silvia Cantara; Alfonso Sagnella; Maria Grazia Castagna
Journal:  Int J Mol Sci       Date:  2022-04-22       Impact factor: 6.208

3.  Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2.

Authors:  Elizabeth Slocum; Amanda Craig; Augusto Villanueva; Doris Germain
Journal:  Breast Cancer Res       Date:  2019-05-02       Impact factor: 6.466

4.  The voltage-gated sodium channel Nav1.7 associated with endometrial cancer.

Authors:  Junxiu Liu; Hao Tan; Wancai Yang; Shuzhong Yao; Liang Hong
Journal:  J Cancer       Date:  2019-08-27       Impact factor: 4.207

5.  Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression.

Authors:  Jun Zhang; Yuan Zhang; Lanjiang Li; Yinghua Nian; Ying Chen; Ruoxia Shen; Xiaoyan Ma
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 6.  Oncofetal Chondroitin Sulfate: A Putative Therapeutic Target in Adult and Pediatric Solid Tumors.

Authors:  Nastaran Khazamipour; Nader Al-Nakouzi; Htoo Zarni Oo; Maj Ørum-Madsen; Anne Steino; Poul H Sorensen; Mads Daugaard
Journal:  Cells       Date:  2020-03-28       Impact factor: 6.600

7.  Prenatal Biochemical Screening and a Woman's Long-Term Risk of Cancer: A Population-Based Cohort Study.

Authors:  Alison L Park; Tianhua Huang; Wendy S Meschino; Javaid Iqbal; Joel G Ray
Journal:  JNCI Cancer Spectr       Date:  2019-10-04

8.  Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up-A CLARICOR Trial Sub-Study.

Authors:  Erik Nilsson; Jens Kastrup; Ahmad Sajadieh; Gorm Boje Jensen; Erik Kjøller; Hans Jørn Kolmos; Jonas Wuopio; Christoph Nowak; Anders Larsson; Janus Christian Jakobsen; Per Winkel; Christian Gluud; Kasper K Iversen; Johan Ärnlöv; Axel C Carlsson
Journal:  J Clin Med       Date:  2020-01-18       Impact factor: 4.241

9.  Epigenetics meets proteomics in an epigenome-wide association study with circulating blood plasma protein traits.

Authors:  Shaza B Zaghlool; Brigitte Kühnel; Mohamed A Elhadad; Sara Kader; Anna Halama; Gaurav Thareja; Rudolf Engelke; Hina Sarwath; Eman K Al-Dous; Yasmin A Mohamoud; Thomas Meitinger; Rory Wilson; Konstantin Strauch; Annette Peters; Dennis O Mook-Kanamori; Johannes Graumann; Joel A Malek; Christian Gieger; Melanie Waldenberger; Karsten Suhre
Journal:  Nat Commun       Date:  2020-01-03       Impact factor: 14.919

10.  Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series.

Authors:  S Cantara; M G Castagna; C Marzocchi; M Capezzone; A Sagnella; A Cartocci; M Caroli Costantini; L Brindisi; V Mancini
Journal:  J Endocrinol Invest       Date:  2021-08-04       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.